|
(866) 998-8855
 |
 |
|
|
 |
Home > Herbs > Milk Thistle *Silymarin* >
Mega Silymarin with Isosilybin B
100 capsules
|
| Milk thistle extract has long been valued for its role in ensuring
healthy liver function.* Milk thistle extract consists of silibinin and
other similar compounds. Until recently, researchers believed that
silibinin was the most biologically active ingredient found in milk
thistle extract. Highly advanced extraction technology has now enabled
scientists to isolate silymarin constituents and to test their efficacy
against various cell lines. Among the compounds tested, a silymarin
constituent called isosilybin B proved to be the most efficient in
maintaining healthy cell division.1*
New Mega Silymarin with Isosilybin B is the first milk thistle extract
to contain standardized, pharmaceutical grade potencies of silymarin,
silibinin and isosilybin B - providing the full spectrum of milk
thistle's liver and prostate protective compounds.
1 Davis-Searles PR, Nakanishi Y, Kim NC.
Cancer Research. 2005 May 15;65(10):4448-57. |
| Supplement Facts |
| Serving Size 1 capsule |
| Servings Per Container 100 |
|
Amount Per Serving |
| Milk Thistle Extract (Silybum
marianum) |
900 mg |
| [standardized to 80%
Silymarin by UV (720 mg), 30% Silibinin by HPLC (270 mg), and
4.5% Isosilybin B by HPLC (40.5 mg)] |
|
| Other
ingredients: gelatin, rice flour, magnesium stearate, silica. |
| This product contains NO wheat, yeast, gluten,
soy, or dairy. Contains NO artificial sweeteners, flavors,
colors, or preservatives. |
|
| Dosage and Use |
- Take one capsule daily or as recommended by a healthcare
practitioner.
- This product can be taken with or without food
Warnings
- Keep out of reach of children.
- Do not exceed recommended dose.
- Do not purchase if outer seal is broken or damaged.
- If you have a bad reaction to product discontinue use
immediately.
- When using nutritional supplements, please inform your physician
if you are undergoing treatment for a medical condition or if you
are pregnant or lactating.
|
| |
|
|
|